Rigel Pharmaceuticals (RIGL) Deferred Taxes (2026)
Rigel Pharmaceuticals (RIGL) reported Deferred Taxes of $5.21 million for Q2 2026, up 102.5% from the prior quarter.
Powered by 
Analysis
Rigel Pharmaceuticals (RIGL) Deferred Taxes (2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Rigel Pharmaceuticals' Deferred Taxes came in at $7.78 million; for FY2025, it came in at -$245.85 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,175.94 Bn | 1,144.53 Bn | 19.71 Bn | 1.05 Bn |
| 2 | Johnson & Johnson | 638.47 Bn | 556.99 Bn | 17.26 Bn | -479.00 Mn |
| 3 | AbbVie | 504.39 Bn | 477.51 Bn | 12.70 Bn | -195.00 Mn |
| 4 | Merck | 377.60 Bn | 331.98 Bn | 12.21 Bn | -544.00 Mn |
| 5 | Novartis Ag | 304.31 Bn | 268.30 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.64 Bn | 241.32 Bn | 12.86 Bn | - |
| 7 | Amgen | 242.06 Bn | 197.45 Bn | 7.24 Bn | -291.00 Mn |
| 8 | Gilead Sciences | 193.83 Bn | 168.03 Bn | 6.22 Bn | -587.00 Mn |
| 9 | Pfizer | 172.62 Bn | 119.27 Bn | 10.94 Bn | -1.32 Bn |
| 10 | Rigel Pharmaceuticals | 918.71 Mn | 384.60 Mn | 70.18 Mn | 5.21 Mn |
API Access
Rigel Pharmaceuticals Deferred Taxes API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=deferred-taxes&ticker=RIGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "deferred-taxes", "ticker": "RIGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=deferred-taxes&ticker=RIGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();